Journal of Endocrinological Investigation

, Volume 23, Issue 1, pp 54–62 | Cite as

Obesity and hypertension

  • Emanuela Faloia
  • G. Giacchetti
  • F. Mantero
Review Article


Obesity hypertension adipose tissue 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kannel W.B., Zhang T., Garrison R.J. Is obesity-related hypertension less of a cardiovascular risk? The Framingham Study. Am. Heart J. 1990, 120: 1195–1201.PubMedCrossRefGoogle Scholar
  2. 2.
    Hall J.E. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension 1994, 23: 381–394.PubMedCrossRefGoogle Scholar
  3. 3.
    Kannel N.B., Brand N., Skinner J.J. Jr, Damber T.R., Mc Namara P.M. The relation of adiposity to blood pressure and development of hypertension. Ann. Intern. Med. 1967, 67: 48–59.PubMedCrossRefGoogle Scholar
  4. 4.
    Reaven G.M. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37: 1595–1607.PubMedCrossRefGoogle Scholar
  5. 5.
    Ferrannini E., De Fronzo R.A. The association of hypertension, diabetes and obesity. J. Nephrol. 1989, 1: 3–15.Google Scholar
  6. 6.
    Must A., Jacques P.F., Bajema C.J., Dietz W.H. Long-term morbidity and mortality of overweight adolescent. N. Engl. J. Med. 1992, 327: 1350–1355.PubMedCrossRefGoogle Scholar
  7. 7.
    Whitaker R.C., Wright J.A., Pepe M.S., Seidel K.D., Dietz W.H. Predicting obesity in young adulthood from childhood and parental obesity. N. Engl. J. Med. 1997, 337: 869–927.PubMedCrossRefGoogle Scholar
  8. 8.
    Saad M.F., Knowler W.C., Pettitt D.J., Nelson R.G., Mott D.M., Bennett P.H. Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians. Diabetes 1990, 39: 1430–1435.PubMedCrossRefGoogle Scholar
  9. 9.
    Van Itallie T.B. Health implications of overweight and obesity in the United States. Ann. Intern. Med. 1985, 103: 983–988.PubMedCrossRefGoogle Scholar
  10. 10.
    Tobian L. Hypertension and obesity N. Engl. J. Med. 1978, 298: 46–47.CrossRefGoogle Scholar
  11. 11.
    Mureddu G.F., De Simone G., Greco R., Rosato G.F., Contaldo F. Left ventricular filling in arterial hypertension: influence of obesity, hemodynamic and structural confounders. Hypertension 1997, 29: 544–550.PubMedCrossRefGoogle Scholar
  12. 12.
    De Simone G., Devereux R.B., Kimball T.R., Mureddu G.F., Roman M.J., Contaldo F., Daniels S.R. Interaction between body size and cardiac workload. Influence on left ventricular mass during body growth and adulthood. Hypertension 1998, 31: 1077–1082.PubMedCrossRefGoogle Scholar
  13. 13.
    Hall J.E. Mechanisms of abnormal renal sodium handling in obesity hypertension. Am. J. Hypertens. 1997, 10: 49S–55S.PubMedCrossRefGoogle Scholar
  14. 14.
    Rocchini A.P. The relationship of sodium sensitivity to insulin resistance. Am. J. Med Sci. 1994, 307: S75–80.PubMedGoogle Scholar
  15. 15.
    Biorntorp P. The regulation of adipose tissue distribution in humans. Int. J. Obes. 1996, 20: 291–302.Google Scholar
  16. 16.
    Haffner S.M., Valdez R.A., Hazuda H.P., Braxton D.M., Morales P.A., Stern M.P. Prospective analysis of the Insulin-resistance Syndrome (Syndrome X) Diabetes 1992, 40: 715–722.CrossRefGoogle Scholar
  17. 17.
    Ferrari P., Weidman P., Shaw S., Giachino D., Riesen W., Alleman Y., Heymen G. Altered insulin sensitivity, hyperinsulinemia and dyslipidemia in individuals with a hypertensive parent. Am. J. Med. 1991, 91: 589–596.PubMedCrossRefGoogle Scholar
  18. 18.
    Faloia E., Garrapa G.G.M., Tortato E., Camilloni M.A., Francucci C.M., Di Marco S., Mantero F. Abdominal fat and cardiovascular risk factors in obese children. Int. J. Obes. 1997, 21: S27.CrossRefGoogle Scholar
  19. 19.
    Hall J.E., Brands M.W., Zappe D.H., Alonso Galicia M. Insulin resistance, hyperinsulinemia, and hypertension: causes, consequences or merely correlations? Proc. Soc. Exp. Biol. Med. 1995, 208: 317–329.PubMedCrossRefGoogle Scholar
  20. 20.
    Muscelli E., Natali A., Branchi S., Bigazzi R., Galvan A.Q., Siron A.M., Frascerra S., Ciociaro D., Ferrannini E. Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am. J. Hypertens. 1996, 9: 746–752.PubMedCrossRefGoogle Scholar
  21. 21.
    Sechi L.A., Griffin C.A., Giacchetti G., Zingaro L., Catena C., Bartoli E., Schambelan M. Abnormalities of insulin receptors in spontaneously hypertensive rats. Hypertension 1996, 27: 955–961.PubMedCrossRefGoogle Scholar
  22. 22.
    Lembo G., Iaccarino G., Vecchione C., Rendina V., Trimarco B. Insulin modulation of vascular reactivity is already impaired in prehypertensive spontaneously hypertensive rats. Hypertension 1995, 26: 290–293.PubMedCrossRefGoogle Scholar
  23. 23.
    Natali A., Galvan A.Q., Pecori N., Sanna G., Toschi E., Ferrannini E. Vasodilation with sodium nitroprusside does not improve insulin action in essential hypertension. Hypertension 1998, 31: 632–636.PubMedCrossRefGoogle Scholar
  24. 24.
    Howard G., O’Leary D.H., Zaccaro D., Haffner S., Rewers M., Hamman R., Selby J.V., Saad M.F., Savage P., Bergman R. Insulin sensitivity and atherosclerosis. Circulation 1996, 93: 1809–1817.PubMedCrossRefGoogle Scholar
  25. 25.
    Reaven G.M., Lithell H., Landsberg L. Hypertension and associated metabolic abnormalities-The role of insulin resistance and the sympathoadrenal system N. Engl. J. Med. 1996, 334: 374–381.PubMedCrossRefGoogle Scholar
  26. 26.
    Davda R.K., Ullian M.E., Stepniakowski K.T., Goodfriend T.L., Egan B.M. Oleic acid inhibits endothelial cell nitric oxide synthase by a PCK-independent mechanism. Hypertension 1995, 26: 764–770.PubMedCrossRefGoogle Scholar
  27. 27.
    Hiramatsu K., Yamada T., Ichikawa K., Izumiyama T., Nagara H. Changes in endocrine activities relative to obesity in patients with essential hypertension. J. Am. Geriatr. Soc. 1982, 29: 25–29.Google Scholar
  28. 28.
    Weinsier R.L., James L.D., Darnell B.E., Dustan H.P., Birch R., Hunter G.R. Obesity related hypertension: evaluation of separate effects of energy restriction and weight reduction on hemodynamic and endocrine status. Am. J. Med. 1991, 90: 460–468.PubMedCrossRefGoogle Scholar
  29. 29.
    Cooper R., McFarlane-Anderson N., Bennet F.I., Wilks R., Puras A., Tewksbury D., Ward R., Forrester T. ACE, angiotensinogen, and obesity: a potential pathway leading to hypertension. J. Hum. Hypertens. 1997, 11: 107–111.PubMedCrossRefGoogle Scholar
  30. 30.
    Tuck M.L., Sowers J., Dornfeld L., Kledzik G., Maxwell M. The effect of weight reduction and blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N. Engl. J. Med. 1981, 304: 930–933.PubMedCrossRefGoogle Scholar
  31. 31.
    Umemura S., Nyui N., Tamura K., Hibi K., Yamaguchi S., Nakamaru M., Ishigami T., Yabana M., Kihara M., Inoue S., Ishii M. Plasma angiotensinogen concentrations in obese patients. Am. J. Hypertens. 1997, 10: 629–633.PubMedCrossRefGoogle Scholar
  32. 32.
    Tamura K., Umemura S., Nyui N., Yamakawa T., Yamaguchi S., Ishigami T., Tanaka S., Tanimoto K., Takagi N., Sekihara H., Murakami K., Ishii M. Tissue specific regulation of angiotensinogen gene expression in spontaneously hypertensive rats. Hypertension 1996, 27: 1216–1223.PubMedCrossRefGoogle Scholar
  33. 33.
    Bloem L.J., Manatunga A.K., Tewksbury D.A., Pratt J.H. The serum angiotensinogen concentration and various of the angiotensinogen genes in white and black children. J. Clin. Invest. 1995, 95: 948–953.PubMedCentralPubMedCrossRefGoogle Scholar
  34. 34.
    Forrester T., Mc Farlane N., Bennet F., Wilks R., Puras A., Cooper R., Rotimi C., Durazo R., Tewkshury D., Morrison L. Angiotensinogen and blood pressure among blacks: findings from a community survey in Giamaica. J. Hypertens. 1996, 14: 315–321.PubMedCrossRefGoogle Scholar
  35. 35.
    Hegele R.A., Brunt J.H., Connelly P.V. Genetic variation on chromosome 1 and associated with variation in body fat distribution in men. Circulation 1995, 92: 1089–1093.PubMedCrossRefGoogle Scholar
  36. 36.
    Jeunemaitre X., Soubrier F., Kotelevtev Y.V., Lifton R.P., Williams C.S., Charru A., Hunt S.C., Hopkins P.N., Williams R.R., Lalouel J.M., Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992, 10: 473–482.Google Scholar
  37. 37.
    Cassis L.A., Saye J., Peach M.J. Location and regulation of rat angiotensinogen messenger RNA. Hypertension 1988, 11: 591–596.PubMedCrossRefGoogle Scholar
  38. 38.
    Harp J.B., Di Girolamo M. Components of renin-angiotensin system in adipose tissue:changes with maturation and mass enlargement. J. Gerontol. A Biol. Sci. Med. Sci. 1994, 50: 270–276.Google Scholar
  39. 39.
    Jones B.H., Sandridge M.K., Taylor J.W., Moustaid N. Angiotensinogen gene expression in adipose tissue: analysis of obese models and hormonal and nutritional control. Am. J. Physol. 1997, 42: R236–R242.Google Scholar
  40. 40.
    Darimont C., Vassaux G., Ailhaud G., Negrel L. Differentiation of preadipose cells: paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin 2. Endocrinology 1994, 135: 2030–2036.PubMedGoogle Scholar
  41. 41.
    Hillgartner F.B., Salati L.M., Goodridge A.G. Physiological and molecular mechanisms involved in nutritional regulation of fatty acid synthesis. Phisiol. Rev. 1995, 75: 47–76.Google Scholar
  42. 42.
    Jones B.H., Standridge M.K., Moustaid N. Angiotensin 2 increases lipogenesis in 3T3-L1 and human adipose cells. Endocrinology 1997, 138: 1512–1519.PubMedGoogle Scholar
  43. 43.
    Benabe J.E., Martinez-Maldonato M. Nutritional influences on renin-angiotensin gene expression. Nutr. Met. Cardiovasc. Dis. 1996, 6: 46–52.Google Scholar
  44. 44.
    Aubert J., Darimont C., Safonova I., Ailhaud G., Negrel R. Regulation by glucocorticoids of angiotensinogen gene espression and secretion in adipose cells. Biochem. J. 1997, 328: 701–706.PubMedCentralPubMedGoogle Scholar
  45. 45.
    Frederich R.C., Kahn B.B., Peach M.J., Flier J.S. Tissue specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 1992, 19: 339–344.PubMedCrossRefGoogle Scholar
  46. 46.
    Velloso L.A., Folli F., Sun X.J., White M.F., Saad M.J.A., Kahn C.R. Cross-talk between the insulin and angiotensin signaling systems. Med. Sciences 1996, 93: 12490–12495.Google Scholar
  47. 47.
    Tamura K., Umumura S., Yamakawa T., Nyui N., Hibi K., Watanabe Y., Yishigami T., Yabana M., Tanaka SI., Sekihara H., Murakami K., Ishii M. Modulation of tissue angiotensinogen gene expression in genetically obese hypertensive rats. Am J. Phisiol. 1997, 272: R1704–R1711.Google Scholar
  48. 48.
    Giacchetti G., Faloia E., Sardu C., Camilloni M.A., Garrapa G.G.M., Guerrieri M., Mantero F. Gene expression of angiotensinogen in adipose tissue of obese patients. Int. J. Obes. 1998, 22 (S3): S102.Google Scholar
  49. 49.
    Pasquali R. Is the hypothalamic-pituitary-adrenal axis really hyperactivated in visceral obesity? J. Endocrinol. Invest. 1998, 21: 268–271.PubMedGoogle Scholar
  50. 50.
    Weaver J.U., Hitman G.A., Kopelman P.G. An association between a Bell restriction fragment lenght polymorphism of the glucocorticoid receptor locus and hyperinsulinemia in obese women. J. Mol. Endocrinol. 1992, 9: 295–300.PubMedCrossRefGoogle Scholar
  51. 51.
    Kenyon C.J., Panarelli M., Holloway C.D., Dunlop D., Morton J.J., Connell J.M.C., Fraser R. The role of glucocorticoid activity in the inheritance of hypertension: studies in the rat. J. Steroid. Biochem. Mol. Biol. 1993, 45: 7–11.PubMedCrossRefGoogle Scholar
  52. 52.
    Mantero F., Masini A.M., Opocher G., Giovagnetti M., Arnaldi G. Adrenal Incidentaloma: an overview of hormonal data from the National Study Group. Horm. Res. 1997, 47: 284–289.PubMedCrossRefGoogle Scholar
  53. 53.
    Reinke M., Fabnacht M., Vath S., Mora P., Allolio B. Adrenal incidentaloma: a manifestation of the metabolic syndrome? Endocr. Res. 1996, 22: 757–761.Google Scholar
  54. 54.
    Bujalska I., Kumar S., Stewart P.M. Does central obesity reflect “Cushing disease of the omentum”? Lancet 1997, 349: 1210–1213.PubMedCrossRefGoogle Scholar
  55. 55.
    Zennaro M.C., Le Menuet D., Viengchareun S., Walker F., Ricquier D., Lombes M. Hibernoma development in transgenic mice identifies brown adipose tissue as a novel target of aldosterone action. J. Clin. Invest. 1998, 101: 1254–1260.PubMedCentralPubMedCrossRefGoogle Scholar
  56. 56.
    Dessì-Fulgheri P., Sarzani R., Tamburrini P., Moraca A., Espinosa E., Cola G., Giantomassi L., Rappelli A. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue in normotensive and hypertensive obese patients. J. Hypertens. 1997, 15: 1695–1699.PubMedCrossRefGoogle Scholar
  57. 57.
    Haynes W.G., Morgan D.A., Walsh S.A., Sivitz W.I., Mark A.L. Cardiovascular consequences of obesity: role of leptin. Clin. Exp. Pharmacol. Physiol. 1998, 25: 65–69.PubMedCrossRefGoogle Scholar
  58. 58.
    Alessi M.C., Peiretti F., Morange P., Henry M., Nalbone G., Juhan-Vague I. Production of Plasminogen Activator Inhibitor 1 by human adipose tissue. Diabetes 1997, 46: 860–867.PubMedCrossRefGoogle Scholar
  59. 59.
    Komers R., Vrana A. Thiazolidinediones: tools for the research of metabolic syndrome X. Physiol. Res. 1998, 47: 215–225.PubMedGoogle Scholar
  60. 60.
    Itoh H., Doi K., Fukunaga Y., Hosoda K., Inoue G., Nishimura H., Yoshimasa Y., Yamori Y., Nakao K. Hypertension and insulin resistance: role of a peroxisome proliferator-activated receptor gamma. Clin. Exp. Pharmacol. Physiol. 1999, 26: 558–560.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2000

Authors and Affiliations

  1. 1.Division of Endocrinology, Department Internal of MedicineUniversity of AnconaAnconaItaly

Personalised recommendations